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Asbestos-related lung disease (ARD), including
ﬁbrosis, pleural plaques, and cancer, continues
to be a serious and signiﬁcant problem despite
increasing awareness of the health hazards of
asbestos inhalation. Although the exact mecha-
nisms leading to the progression of these con-
ditions have not been fully explained, there is
evidence that some of the lung pathologies
seen with both asbestos and silica exposures are
immunologically mediated (Hamilton et al.
1996; Holian et al. 1997; Perkins et al.
1993). Silica and asbestos exposures also both
appear to exacerbate autoimmune responses.
Epidemiologic studies have shown strong asso-
ciations between silica exposure and several
autoimmune diseases, including scleroderma,
systemic lupus erythematosus (SLE), and
rheumatoid arthritis (RA) (Koeger et al. 1995;
Parks et al. 1999; Powell et al. 1999; Steenland
and Goldsmith 1995). Increased serum
immunoglobulins, positive antinuclear anti-
body (ANA) tests, and immune complexes
have been reported in small cohorts of indi-
viduals exposed to asbestos (Lange 1980;
Nigam et al. 1993; Zerva et al. 1989), but to
our knowledge no comprehensive study has
been undertaken to assess the prevalence,
speciﬁcity, and signiﬁcance of autoantibodies
associated with asbestos exposures. The popu-
lation in Libby provides a unique research
opportunity because of significant exposures
that occurred as a result of the mining of
asbestos-contaminated vermiculite near the
community. Exposures have been documented
not only in the miners but also in their family
members, as well as anyone who used the ver-
miculite or played near the mine tailings.
Therefore, the Libby asbestos exposures were
both occupational and environmental through-
out the community (Peipins et al. 2003).
In addition to the ARD in Libby, there
have been anecdotal reports of an increased
prevalence of systemic autoimmune disease
(SAID), but veriﬁcation of these diagnoses is
still in progress. When the Centers for Disease
Control and Prevention/Agency for Toxic
Substances and Disease Registry (ATSDR)
performed its screening in Libby during
2000–2001, 494 (6.7%) of 7,307 screening
participants indicated that they had been diag-
nosed with either SLE, scleroderma, or RA
(Larson T, personal communication). In con-
trast, a prevalence of < 1% for these three con-
ditions combined would be expected based on
pooled estimates from 43 prevalence studies
(Jacobson et al. 1997). These data, along with
extensive evidence of silica-associated auto-
immunity, provided the impetus to initiate a
multifaceted assessment of the impact of
asbestos exposures on the population of Libby,
Montana, including possible autoimmune
responses.
In this article we report on a study
designed to assess whether there were humoral
alterations in serum samples from an
asbestos-exposed population (Libby samples)
that might indicate autoimmune responses,
providing the rationale for future full-scale
studies. Serum samples of subjects from
Libby and from a Montana community with
no reported asbestos exposure were assayed
for a variety of immune parameters, including
ANA, immunoglobulin A (IgA), rheumatoid
factor (RF), and antibodies to extractable
nuclear antigens (ENA).
Materials and Methods
Human samples. All samples were acquired
according to approved University of Montana
institutional review board protocols, protect-
ing the well-being and confidentiality of all
subjects. Appropriate informed consent was
obtained from all subjects, and a question-
naire was administered regarding overall
health, smoking status, asbestos exposure,
age, sex, and recontact information.
Two sample pools were obtained through
other studies at the Center for Environmental
Health Sciences. Subjects were recruited
through ﬂyers and ads in Missoula, Montana,
for a study of immune function (E. Putnam),
and serum samples were collected at the same
time for convenience. Missoula is similar to
Libby in that it is located in a mountain valley
subject to similar climatic conditions, includ-
ing winter inversions, dry summers, and expo-
sure to smoke from fall forest fires. Because
prevailing winds in Missoula are from the west
and Libby is well to the north, there would be
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Systemic autoimmune responses are associated with certain environmental exposures, including
crystalline particles such as silica. Positive antinuclear antibody (ANA) tests have been reported in
small cohorts exposed to asbestos, but many questions remain regarding the prevalence, pattern,
and significance of autoantibodies associated with asbestos exposures. The population in Libby,
Montana, provides a unique opportunity for such a study because of both occupational and
environmental exposures that have occurred as a result of the mining of asbestos-contaminated
vermiculite near the community. As part of a multifaceted assessment of the impact of asbestos
exposures on this population, this study explored the possibility of exacerbated autoimmune
responses. Age- and sex-matched sets of 50 serum samples from Libby and Missoula, Montana
(unexposed), were tested for ANA on HEp-2 cells using indirect immunofluorescence. Data
included frequency of positive tests, ANA titers, staining patterns, and scored ﬂuorescence inten-
sity, all against known controls. Serum immunoglobulin A (IgA), rheumatoid factor, and anti-
bodies to extractable nuclear antigen (ENA) were also tested. The Libby samples showed
signiﬁcantly higher frequency of positive ANA and ENA tests, increased mean ﬂuorescence inten-
sity and titers of the ANAs, and higher serum IgA, compared with Missoula samples. In the Libby
samples, positive correlations were found between ANA titers and both lung disease severity and
extent of exposure. The results support the hypothesis that asbestos exposure is associated with
autoimmune responses and suggests that a relationship exists between those responses and
asbestos-related disease processes. Key words: asbestos, ANA, environmental autoimmunity,
immunotoxicology. Environ Health Perspect 113:25–30 (2005). doi:10.1289/ehp.7431 available
via http://dx.doi.org/ [Online 30 September 2004]no transfer of asbestos from the Libby airshed
to the Missoula airshed. Therefore, on a rela-
tive basis, although one cannot exclude the
possibility that there could have been some
minimal asbestos exposure by the Missoula
population, it is an acceptable reference popu-
lation for the Libby subjects who were defi-
nitely exposed to asbestos. For this study, we
selected 50 samples from subjects with no
reported asbestos exposure from the Missoula
pool, excluding any who had lived or worked
in Libby. Concurrently, subjects were being
recruited from Libby, Montana, for a genetic
study of ARD susceptibility (E. Putnam), and
the samples were drawn at the Center for
Asbestos Related Diseases Clinic in Libby
when subjects came for screening or responded
to subject recruitment advertisements. From
this pool, 50 Libby subjects were selected that
were matched to the 50 Missoula subjects to
give similar mean age and sex ratios for the two
subject sets. Permission was obtained to
acquire information about prescription drug
use and ARD status from medical records, and
these data were inserted into a coded database.
Both communities from which subjects
were drawn are fairly homogeneous in terms of
ethnicity; most residents are of northern
European descent, with 94.7% white in
Lincoln County (Libby) and 93.6% white in
Missoula County (Missoula) according to
Montana census data (U.S. Census Bureau
2004). The mean age for both sample sets was
55 years (Missoula, 54.8 ± 2.5 years; Libby,
55.0 ± 2.1 years), and the male:female ratio
was 25:25 for both sets. An exclusion criterion
was the use of medications strongly associated
with drug-induced autoimmunity (Fritzler
1994). The presence of diagnosed autoim-
mune disease did not exclude individuals from
either sample set but was noted on intake.
None of the Missoula subjects recruited had
diagnosed SAID. Of the Libby subjects
recruited initially for the genetics study, the per-
centage with diagnosed SAID was 5.9%, and in
the ﬁnal Libby sample set of 50, there were two
with SLE, 1 with multiple sclerosis, and 1 with
RA. Because the individual with RA also had
SLE, this means that three people in 50 had
SAID (6%). These values are consistent with
the ATSDR screening data for this community
(Larson T, personal communication).
The lung diseases in this community have
been previously described (Peipins et al.
2003) and include primarily pleural abnor-
malities (17.8%) and interstitial abnormalities
(< 1%). In our Libby sample set, 12 (24%)
had no reported abnormalities, 27 (54%) had
pleural abnormalities, 8 (16%) had interstitial
abnormalities, and 3 (6%) had a combination
of pleural and interstitial abnormalities.
Sample and data collection. The blood
samples were collected, and serum samples
were obtained and frozen by standardized
clinical methods to prevent differences due to
handling. The samples were blinded with
only sex and age noted, and stored at –80°C
until assayed. After testing, coded informa-
tion regarding disease status and exposure was
obtained from the questionnaire and ATSDR
screening data (ATSDR 2002).
ARD and asbestos exposure rankings.
ARD status, based on data recorded in the
database primarily as a result of the ATSDR
screenings, was ranked on a scale of 0–3, as
described in Table 1. The rankings were
intentionally simpliﬁed, based on radiographic
evidence of single versus extensive plaques or
interstitial abnormalities, as well as spirometry
evidence of functional deﬁcits. For example, a
subject with a single pleural plaque and no
functional deficit would be scored at 1,
whereas a subject with bilateral plaques and
effects on spirometry was scored at 3. To fur-
ther break down the sample sets by disease
types would have made the subsets too small
for statistical analysis. Exposure status was
ranked on a scale of 0–4, as described in
Table 2. These scores were also simpliﬁed in
order to focus on duration of exposure and the
existence of occupational and/or environmen-
tal exposure to asbestos. The rankings of the
Libby subjects were performed independently
by two of the researchers (J.C.P. and E.A.P.).
Autoantibody testing. A clinical test for
nuclear antigens (ANA assay), used to screen
for antibodies commonly seen in SAID, was
performed at a screening dilution of the sera.
All serum samples were diluted 1:40 in phos-
phate-buffered saline (PBS) and tested by
indirect immunoﬂuorescence (IIF) on a single
lot of commercially prepared and ﬁxed HEp-2
cells (ImmunoConcepts Inc., Sacramento,
CA), according to manufacturer’s instruc-
tions. The staining pattern and relative ﬂuo-
rescence intensity were compared with known
positive and negative controls using a Zeiss
fluorescence microscope with 40× objective
and recorded as positive (1+ to 4+) or nega-
tive (0). The staining pattern was also noted
and recorded. The same microscope and set-
tings were used for all samples, and the slides
were read by two independent readers.
Samples showing homogeneous staining pat-
terns were reevaluated using the Crithidia
luciliae substrate (ImmunoConcepts), which
specifically detects antibodies to double-
stranded DNA (dsDNA), and by enzyme-
linked immunosorbent assay (ELISA) to
detect antibodies to chromatin (INOVA
Diagnostics, San Diego, CA), both according
to the manufacturers’ instructions. Samples
with positive ANAs were also evaluated using
a modified ANA test to determine whether
any of the anti-ANA antibodies were of the
IgA isotype. The samples were tested on
HEp-2 slides as above, but instead of the anti-
human IgG ﬂuorescein isothiocyanate (FITC)
conjugate included with the slides, we used
goat anti-human IgA FITC conjugate
(Southern Biotech, Birmingham, AL). The
slides were read as described above.
IgA ELISA. For detection of serum IgA,
the mucosal antibody isotype, 96-well polysorb
plates (Nunc, Rochester, NY) were coated with
1 µg/mL of anti-human kappa light chain
(Southern Biotech) in carbonate coating buffer
overnight at 4°C. Wells were then blocked
with PBS containing 1% bovine serum albu-
min (BSA) for 1 hr. Subject samples were
diluted 1:4,000, 1:8,000, and 1:16,000 in dilu-
ent buffer (PBS, 1% BSA, 0.1% Tween-20).
Samples, standards, and blanks were added to
wells to give 100 µL/well. After 1 hr, plates
were washed with three changes of PBS con-
taining 0.1% Tween-20. The detection anti-
body [goat anti-human IgA alpha chain
coupled to horseradish peroxidase (HRP);
Caltag, Burlingame, CA] was added and the
plates were incubated for 1 hr at room temper-
ature. The plates were washed again and devel-
oped using HRP-tetramethylbenzidine (TMB)
substrate (Zymed, San Francisco, CA). The
reaction was stopped with 2N H2SO4, and the
plate was read on a SpectraMax plate reader
(Molecular Devices, Sunnyvale, CA). All data
were evaluated against a standard curve, using
human IgA (Sigma, St. Louis, MO).
RF ELISA. RF in the subjects’ serum was
measured with an ELISA kit according to the
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Table 2. Asbestos exposure scores determined from screening data.
Asbestos exposure Criteria used Ordinal value
None No reported occupational or environmental  0
asbestos exposure
Minimal < 5 years, only occupational or environmental 1
Low < 5 years, both occupational and environmental 2
Moderate > 5 years, only occupational or environmental 3
High > 5 years, both occupational and environmental 4
Table 1. Simple classiﬁcation of ARD severity.
Disease severity Criteria used Ordinal value
None No reported lung pathology 0
Limited Unilateral radiograph abnormality 1
Moderate Bilateral abnormality, minimal functional deﬁcit 2
Severe Bilateral abnormality, severe or progressive functional deﬁcit 3manufacturer’s protocol (INOVA Diagnostics).
The plates were read on the SpectraMax plate
reader. Optical density (OD) values were com-
pared with known controls provided with the
kit and rated as negative or positive (marginal,
moderate, or high).
ENA array. Analyses of antibodies to ﬁve
extractable nuclear proteins commonly seen
in SAID (Sm, RNP, SS-A, SS-B, and Scl-70)
were performed using an addressable bead
array kit (QuantaPlex ENA-5; INOVA
Diagnostics) according to the manufacturer’s
instructions, on a Luminex multiplex system
(MiraiBio, Alameda, CA). The values were
compared by using MasterPlex software
(MiraiBio) to negative and graduated positive
control reagents provided with the kit, and
determined to be low, moderate, or high posi-
tive, or negative.
Statistics. In this study we included analy-
sis of several different types of data, including
percentages/frequencies (e.g., ANA frequen-
cies), ordinal (e.g., disease status assessed on a
4-point scale), and scale (e.g., mg/mL IgA)
data. Consequently, we used the following sta-
tistical methods: a) differences in percentages
were tested using raw frequencies with Fisher’s
exact test; b) contingency tables with 4- and
5-point ordinal level frequency comparisons
were made via the chi-square test; and c) inde-
pendent sample t-tests were used for scale
measures. In the Libby samples, comparisons
(correlations) between ANA levels and disease
and exposure rankings were made using the
nonparametric Spearman rank correlation. In
all analyses we used two-tailed, unpaired
analyses, and reported 0.05 type I error levels.
Data reported in the text are mean ± SEM.
Results
Frequency and ﬂuorescence intensity of positive
ANAs. The 50 serum samples in each set were
tested by IIF and were determined to be posi-
tive or negative for ANA based on known con-
trols. Figure 1A shows that the relative
frequency of positive ANAs was 28.6% higher
in the Libby sample set than in the Missoula
set (p = 0.006). Because low-titer positive
ANAs are fairly common in normal popula-
tions, the ANA slides were scored for ﬂuores-
cence intensity. The scored mean ﬂuorescence
intensity of positive ANAs, rated on a scale of
1–4 against known controls, was higher in the
Libby sample set (mean = 2.34 ± 0.153) com-
pared with those from Missoula (1.76 ± 0.194;
p = 0.02), and the distribution of subjects
receiving the various scores was shown to be
signiﬁcantly different between the sample sets
(p = 0.004; Figure 1B). The scored fluores-
cence intensity is not a direct quantiﬁcation of
autoantibodies but generally suggests a higher
titer. Therefore, the positive samples were sub-
sequently titered to 1:1,280 and further ana-
lyzed for ANA. In both groups, the ANA
scores and titers were highly correlated, sug-
gesting that the scoring provides a close estima-
tion of titer (Missoula: correlation coefﬁcient =
0.502, p < 0.001; Libby: correlation coefﬁcient
= 0.828, p < 0.001; Table 3). We found that
the distribution of titers for samples in the two
sample sets were significantly different
(p = 0.036; data not shown). The percentage of
subjects having a positive ANA at a titer ≥ 320
is shown in Figure 1C, again showing a signiﬁ-
cant difference between the two sample sets.
IgA levels and RF. Because other studies
of asbestos-exposed populations have shown
differences in serum IgA compared with
unexposed subjects, serum IgA levels were
analyzed by ELISA in our sample sets. The
Libby samples showed significantly higher
levels of serum IgA than the Missoula samples
(Figure 2). Although both sample sets had
mean IgA concentrations within normal
ranges (~ 0.9–4.5 mg/mL), the Libby mean
was at the high end of the range (4.2 mg/mL).
The ANA tests were subsequently modiﬁed to
detect IgA rather than IgG, and all of the
ANA tests were negative in both sample sets,
indicating that the autoantibodies were most
likely primarily IgG and not IgA (data not
shown).
RF consists of IgM or IgG antibodies
directed against the constant domain of
immunoglobulin. These autoantibodies can
lead to immune complex deposition in tissues
and are associated with a variety of infectious
and inﬂammatory disorders such as RA. The
samples were evaluated for IgM RF by ELISA,
and there were no differences in either the
mean OD calculated for each sample set or the
frequency of positive tests for RF (Figure 3).
Staining patterns on ANAs. To determine
the speciﬁc targets for the IgG autoantibodies,
we analyzed the patterns visible on the ANA
tests. In the Missoula samples, a nuclear speck-
led staining pattern was most common, as
expected in a normal population (speckled,
14%; homogeneous, 12%; nucleolar, 10%).
Other staining patterns were relatively rare, as
expected. However, in the Libby samples,
homogeneous (indicative of antibodies to chro-
matin) and nucleolar staining patterns were
more prevalent, although the differences were
not statistically significant (speckled, 18%;
homogeneous, 22%; nucleolar, 18%). We
tested for specific antibodies related to these
IIF patterns using an ELISA for chromatin and
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Table 3. Correlation coefﬁcients (CC) with immune
parameters in the Libby cohort.
Parameter analyzed Age ANA titer
ANA score
CC 0.399** 0.828**
Signiﬁcance (two-tailed) 0.004 0.00
No. 51 50
ANA titer
CC 0.381** 1.00
Signiﬁcance (two-tailed) 0.006
No. 50
IgA (mg/mL)
CC –0.009 –0.278
Signiﬁcance (two-tailed) 0.953 0.075
No. 43 42
RF (OD)
CC 0.331* 0.351*
Signiﬁcance (two-tailed) 0.030 0.023
No. 43 42
*Correlation is significant at the 0.05 level (two-tailed
Spearman’s rho test). **Correlation is significant at the
0.01 level (two-tailed Spearman’s rho test).
Figure 1. Comparison of ANA in Libby samples with the Missoula samples. (A) Positive and negative tests
determined based on known controls provided with the kits (*p = 0.004, Fisher’s exact test; n = 50). (B) ANA
ﬂuorescence intensity score based on known controls (p = 0.004, Pearson chi-square test). (C) Percentage
in each group with a titer > 320 (**p < 0.01, Fisher’s exact test; n = 50). ANA tests were performed as
described in “Materials and Methods.” Groups were screened at a serum dilution of 1:40 and read by two
readers; positive tests were then titered to 1:1,280.
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Figure 2. Serum IgA levels were significantly
higher in the Libby group. Serum IgA was meas-
ured by ELISA using anti-human IgA capture and
detection (HRP-conjugated) antibodies from
Southern Biotech and Caltag, respectively. The
samples were tested in duplicate, developed using
TMB, and read on a SpectraMax plate reader. OD
was compared with a standard curve (human IgA,
Sigma) to calculate values (mg/mL, n = 50).
*p = 0.002, two-tailed t-test.
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*an IIF assay for anti-dsDNA (Crithidia luciliae
test). The results indicated that although 22%
of the Libby group had homogeneous staining
patterns, less than half of those were positive
for either chromatin or dsDNA (Figure 4).
This suggests that either individual histones
not available for binding in chromatin prepara-
tions (i.e., H3, H4) or other components of
chromatin may be the targets being recognized
by the autoantibodies in these individuals.
Serum antibodies to ENAs. To further
explore possible targets for the autoantibodies,
we used a Lumine multiplex analyzer with an
addressable laser bead immunoassay to detect
antibodies to ﬁve ENAs. Twelve of the Libby
samples (24%) had positive ENA tests, with
most of the positive samples having more than
one of the antibody speciﬁcities. The Missoula
sample set had only two samples (4%) with
positive ENA tests. These differences were sta-
tistically significant by Fisher’s exact test
(p = 0.004; data not shown). Figure 5 shows
the distribution of positive tests in each group
for all ﬁve antigens tested.
Immune parameter correlations. Table 3
shows statistical correlations among tested
immune parameters within the Libby sample
set, using Spearman’s rho nonparametric test.
As might be expected based on the epidemiol-
ogy of autoimmune diseases, the age of the
individual was positively correlated with the
ANA titer, ANA score, and RF. RF was also
correlated with ANA titer. IgA levels were not
correlated with any other parameter, so the
physiologic signiﬁcance of the elevation seen
in the Libby samples remains unclear.
Correlation of assay results with extent of
exposure and ARD. In addition to the correla-
tions shown above, the immune parameters
were analyzed against the scores of exposure
levels and ARD status, as described in
“Materials and Methods.” Table 4 shows that
there were significant positive associations
between ANA titers and both asbestos expo-
sure and disease status. Because a central
hypothesis relating to asbestos toxicology is
that asbestos exposure is positively associated
with ARD, we tested that correlation using
our scoring system. The correlation between
disease and exposure was 0.239, consistent
with the hypothesis (Table 4).
The analysis for asbestos exposure was per-
formed using the graded system described in
Table 2, but in looking at the data, it was
apparent that the largest effect on ANA titer
was seen in terms of length of exposure rather
than the source (occupational or environ-
mental). Figure 6A shows the mean ANA titers
for the Libby samples when subgrouped by
duration of exposure and demonstrates that the
titers were signiﬁcantly higher for those sub-
jects exposed to asbestos for > 5 years. When
samples were separated according to whether
the subject was exposed environmentally or
occupationally, no significant difference in
mean ANA titer was observed in those two
groups (Figure 6B). This suggests that the
duration of exposure had a greater impact on
autoimmune responses than the source of
exposure. It should be noted that none of the
subjects reported solely occupational exposures;
all also had environmental exposures as well.
Discussion
By demonstrating an association between
asbestos exposure and measures of auto-
immune responses, this study supports and
augments other existing evidence that, like sil-
ica, asbestos is an agent of systemic auto-
immunity. Asbestos-contaminated vermiculite
from Libby has been shipped and processed in
many sites in the United States, and this mate-
rial is still used in many applications. It there-
fore remains a significant health risk to
humans both occupationally and environ-
mentally, and an awareness of an association
with autoimmunity could impact necessary
monitoring, testing, and treatment regimens
for exposed individuals or populations.
In addition, this study establishes the
Libby population as an excellent cohort for
further study of the immunologic aspects of
asbestos toxicology. It is a unique population
with both occupational and environmental
exposures, excellent ongoing monitoring and
demographic data, enthusiasm for participa-
tion in these studies, and sufﬁcient numbers
of exposed individuals to develop sample sets
with adequate power for statistical analyses of
many parameters. The objective of this study
was to compare the frequency of serum auto-
antibodies in two matched populations, one
of them having signiﬁcant asbestos exposure.
It was designed as an initial study in order to
explore the feasibility and justification for a
more extensive study of autoimmunity in the
Libby population.
Previous studies have measured several
immune parameters in populations exposed,
primarily occupationally, to asbestos. Nigam
et al. (1993) demonstrated increased IgG and
IgA and positive ANAs in asbestos-exposed
individuals compared with controls, even in
the absence of apparent ARD. This finding
suggested that immune alterations may pre-
cede the onset of ARD. A high frequency of
positive ANAs was also found in a Japanese
group of asbestos plant workers (Tamura et al.
1993). Interestingly, a 3-year follow-up study
of the Japanese group showed signiﬁcant cor-
relation of positive ANAs with progression of
the disease, leading to additional diagnoses of
asbestosis in a previously healthy group
(Tamura et al. 1996); this suggests that auto-
immunity may play a role in ARD. Because
that important observation needs to be con-
ﬁrmed, the present study also forms the basis
for a similar progressive study of the Libby
population to explore the temporal relation-
ship between autoimmunity and ARD. If
autoimmune responses play a role in the pro-
gression of ARD, this would become an
important target for therapeutic strategies.
A higher frequency of positive ANA was
seen in the Libby sample set compared with
the samples from Missoula, even though the
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Figure 3. Evaluation for IgM RF by ELISA. Neither
the percent positive (based on kit positive and neg-
ative controls) nor the mean OD calculated for
each group was statistically significant (Fisher’s
exact test and t-test, respectively).
Figure 4. Assessment of autoantibodies targeted to
dsDNA or chromatin in subjects with homogeneous
ANA patterns. See “Materials and Methods” for
details. Tests for antibodies to individual histones
were not performed, but that target is indicated for
those homogeneous patterns without antibodies to
dsDNA or chromatin itself.
Figure 5. Increased frequency of positive ENA tests
in Libby samples compared with Missoula samples.
Tests were performed as described in “Materials
and Methods.” Numbers above the bars are p-values
indicating the statistical difference between Libby
samples and Missoula samples (determined by
Fisher’s exact test; n= 50).
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Target antigensMissoula ANA positive frequency was fairly
high (40%). This high “normal” frequency
may be due to the age of the population, the
low dilution used (1:40) for the screening, or
other unidentiﬁed population considerations.
Nevertheless, the Libby sample set showed a
28.6% increase above that seen for the
Missoula samples. In addition, the mean ﬂuo-
rescence intensity of the ANAs, as well as the
titers, were higher in the Libby samples com-
pared with the Missoula samples. Although
higher titers of autoantibodies are not neces-
sarily correlated with an autoimmune disease
process, in some cases increased titers can indi-
cate an exacerbation, relapse, or stage of an
autoimmune process.
Other immune parameters showed differ-
ences in the Libby group as well, including
increases in serum IgA. Serum IgA is generally
found at relatively low levels, but increased
levels are associated with some chronic
inﬂammatory disorders, such as occupational
lung disease, psoriatic arthritis, Crohn’s dis-
ease, and ankylosing spondylitis (Hoffman
et al. 2003; Lindqvist et al. 2002; Zhestkov
2000). The significance of increased serum
IgA levels in the Libby samples is not clear,
but it is consistent with other studies of
asbestos-exposed subjects (Nigam et al. 1993;
Zerva et al. 1989). We demonstrated that the
autoantibodies detected by ANA were not of
the IgA isotype, so it is possible that the IgA
antibodies are simply elicited by nonspecific
chronic inﬂammatory processes in these indi-
viduals. This possibility is supported by the
lack of correlation between IgA titers and
either ANA or asbestos exposure; however, a
correlation between IgA titers and disease sta-
tus was also lacking in our analysis.
We found no difference between the two
sample sets in terms of frequency of positive
tests for RF, and in general the positive sam-
ples in both groups were rated marginal to
moderate when compared with known con-
trols (data not shown). There was also no cor-
relation between RF and asbestos exposure.
These results suggest that asbestos exposure is
not associated with increases in RF, especially
because previous studies of asbestos-exposed
populations have not consistently reported
elevated RF. Interestingly, we found a posi-
tive association of RF with lung disease status.
This may suggest that the presence of RF is
more dependent on the chronic inﬂammation
resulting from the ARD than on asbestos
exposure itself. Alternatively, because there
were positive correlations between RF and
both ANA titer and ARD, the threshold of
asbestos exposure impacting development of
RF may simply be too low to be detected
using the simpliﬁed exposure scale (Table 2).
Therefore, the pathophysiologic significance
of these results remains to be determined with
further study. Although assaying RF is a good
screening tool, it is not specific for RA. An
alternative test would be an assay for cyclic
citrullinated peptide (CCP), a more specific
epitope characteristic of autoantibodies in RA
(Bombardieri et al. 2004; Saraux et al. 2003)
because CCP can antedate clinical RA.
The Libby sample set had a significantly
higher number of total positive ENA subjects
(24% vs. 4% in the Missoula group). ENAs are
defined target antigens in a variety of auto-
immune diseases, including systemic lupus,
mixed connective tissue disease, systemic sclero-
sis, and polymyositis (Pahor et al. 1998). In
HEp-2 cells, most of these antibodies produce a
speckled or atypical speckled pattern.
Therefore, our combined data suggest that the
major responses in asbestos-exposed individuals
include antibody development to targets such
as chromatin components (i.e., histone) or
nucleolar components (ﬁbrillarin, DNA topo-
isomerase I), which give the homogeneous
and nucleolar patterns, and several ENAs that
give the speckled pattern. There are auto-
antibodies—other than those detected by the
assay used here—that could give the speckled
patterns seen in both populations. Analysis of
a more comprehensive array of autoantigens
may provide more insight into the spectrum
of autoantibodies related to asbestos exposure.
The presence of autoantibodies does not
necessarily suggest a disease process. However,
to begin to explore a possible role of these
antibodies in the health of the population in
Libby, data regarding the extent of ARD
severity were gathered as described in
“Materials and Methods.” Extent of exposure
included both duration and site of exposure
(work vs. recreational/home). The data
showed that individuals with longer exposures,
and especially if exposed both at work and at
home, had higher ANA titer than those with
shorter exposures (< 5 years). Disease status
considered the extent of ﬁbrosis or plaquing,
as well as functional deﬁcits. Again, the data
showed increasing ANA titer with increasing
disease severity. The stronger correlation
between ANA titer and disease than between
ANA titer and exposure may be due to impre-
cise scoring systems. Exposure and ARD are
assumed to be correlated (Peipins et al. 2003),
even though this correlation was only at the
90th percentile using our scoring systems.
Therefore, these data do not exclude the possi-
bility that the correlation of ANA titer with
exposure may be secondary to the chronic
inﬂammation and tissue damage of the associ-
ated ARD. It is interesting to note, however,
that of those 494 participants from the Libby
Tremolite Asbestos Registry cohort with sus-
pected SAID, 171 (35%) have had pleural
and/or interstitial abnormalities indicated on
chest radiographs and confirmed by two
B-readers (Larson T, personal communica-
tion). These cross-sectional findings suggest
that the proportion of radiographic abnormal-
ities among participants with suspected SAID
(35%) was almost double the proportion of
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Table 4. Correlation coefficients (CC) between
immune parameters and scores both of asbestos
exposure and of asbestos-related disease.
Parameter analyzed Exposure ARD
Age
CC –0.015 0.304*
Signiﬁcance (two-tailed) 0.920 0.034
No. 51 49
ANA score
CC 0.252 0.295*
Signiﬁcance (two-tailed) 0.074 0.040
No. 51 49
ANA titer
CC 0.366** 0.392**
Signiﬁcance (two-tailed) 0.009 0.006
No. 50 48
RF (OD)
CC 0.129 0.388*
Signiﬁcance (two-tailed) 0.410 0.010
No. 43 43
Exposure
CC 1.00 0.239
Signiﬁcance (two-tailed) 0.098
No. 49
IgA
CC –0.167 –0.090
Signiﬁcance (two-tailed) 0.283 0.567
No. 43 43
*Correlation is significant at 0.05 (two-tailed Spearman’s
rho test). **Correlation is significant at 0.01 (two-tailed
Spearman’s rho test).
Figure 6. ANA titer (mean ± SD) for subsets of the Libby samples based on length of asbestos exposure (A)
or source of exposure (B) as environmental (household contact, used in garden, etc.) or occupational
(worked in vermiculite mine or processing).
*p < 0.01 by two-tailed t-test.
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rradiographic abnormalities among the entire
Libby cohort (~ 18%) (Peipins et al. 2003).
Further study is required to determine if, and
how, autoimmune responses are related to
ARD and whether autoimmunity influences
ARD progression.
Conclusion
We have established that there are signiﬁcant
differences in frequency and titer of positive
ANA tests, frequency of positive ENA tests,
and higher levels of serum IgA when an
asbestos-exposed Libby cohort was compared
with one from Missoula with no reported
asbestos exposures. We have also shown sig-
nificant associations between asbestos expo-
sure and ANA titer. These data support the
hypothesis that asbestos exposure is associ-
ated with autoimmune responses. The corre-
lations of ARD with ANA titer, ANA score,
and RF suggest the possibility that auto-
immunity could play a role in the progres-
sion of ARD. This study provides the
foundation and justification for a larger and
more extensive study, planned to explore
these associations much more rigorously.
These studies will increase our understand-
ing of the immune components of ARD and
could lead to improved interventions as an
ultimate goal of the discovery of interrelated
pathologies.
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